Latest Breaking News On - Staff of the listing qualifications department - Page 3 : comparemela.com

INSEEGO CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On March 24, 2023, Inseego Corp. received a written notice from the. | March 30, 2023

Hearing panelStaff of the listing qualifications departmentNasdaq hearing panelInseego corpContinued listing ruleListing qualifications departmentNasdaq stock marketNasdaq global select marketNasdaq listing ruleBid priceCommon stockMinimum bid priceCompliance period ruleNasdaq global selectMinimum bid price requirementCompliance date

NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing

NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.

Alex zwyerCindy rizzoNasdaq hearings panel theEuropean medicines agencyNasdaq stock marketStaff of the listing qualifications departmentCompany of the staffPharmaceutics ltdListing qualifications departmentNasdaq hearings panelNasdaq capital marketNasdaq listing ruleNasdaq listing rulesOrphan disease designationMazindol controlled releaseOrphan drug designations

NLS Pharmaceutics (NLSP) Receives Delisting Determination from Nasdaq

NLS Pharmaceutics (NLSP) Receives Delisting Determination from Nasdaq
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Nasdaq hearings panel theNasdaq stock marketStaff of the listing qualifications departmentCompany of the staffPharmaceutics ltdListing qualifications departmentNasdaq hearings panelNasdaq capital marketNasdaq listing ruleNasdaq listing rules

NLS Pharmaceutics AG: NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing

ZÜRICH, SWITZERLAND / ACCESSWIRE / October 5, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery

Alex zwyerCindy rizzoNasdaq hearings panel theEuropean medicines agencyNasdaq stock marketStaff of the listing qualifications departmentCompany of the staffPharmaceutics ltdListing qualifications departmentNasdaq hearings panelNasdaq capital marketNasdaq listing ruleNasdaq listing rulesOrphan disease designationMazindol controlled releaseOrphan drug designations

NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing

NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.